Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113226658 | 11322665 | 8 | F | 20130614 | 20160621 | 20150730 | 20160701 | EXP | CA-ROCHE-1614436 | ROCHE | 53.45 | YR | F | Y | 0.00000 | 20160701 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113226658 | 11322665 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0059B,S0062 | 103976 | 375 | MG | SOLUTION FOR INJECTION | QOW | |||||
| 113226658 | 11322665 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0059B,S0062 | 103976 | SOLUTION FOR INJECTION | ||||||||
| 113226658 | 11322665 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0059B,S0062 | 103976 | SOLUTION FOR INJECTION | ||||||||
| 113226658 | 11322665 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0059B,S0062 | 103976 | SOLUTION FOR INJECTION | ||||||||
| 113226658 | 11322665 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0059B,S0062 | 103976 | SOLUTION FOR INJECTION | ||||||||
| 113226658 | 11322665 | 6 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0059B,S0062 | 103976 | SOLUTION FOR INJECTION | ||||||||
| 113226658 | 11322665 | 7 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0059B,S0062 | 103976 | SOLUTION FOR INJECTION | ||||||||
| 113226658 | 11322665 | 8 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0059B,S0062 | 103976 | SOLUTION FOR INJECTION | ||||||||
| 113226658 | 11322665 | 9 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0059B,S0062 | 103976 | SOLUTION FOR INJECTION | ||||||||
| 113226658 | 11322665 | 10 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 0 | ||||||||||||
| 113226658 | 11322665 | 11 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 0 | ||||||||||||
| 113226658 | 11322665 | 12 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 0 | ||||||||||||
| 113226658 | 11322665 | 13 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | 0 | ||||||||||||
| 113226658 | 11322665 | 14 | C | AVAMYS | FLUTICASONE FUROATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113226658 | 11322665 | 1 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 113226658 | 11322665 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113226658 | 11322665 | Asthenia | |
| 113226658 | 11322665 | Asthma | |
| 113226658 | 11322665 | Blood pressure decreased | |
| 113226658 | 11322665 | Bronchitis | |
| 113226658 | 11322665 | Dyspnoea | |
| 113226658 | 11322665 | Eczema | |
| 113226658 | 11322665 | Erythema | |
| 113226658 | 11322665 | Fall | |
| 113226658 | 11322665 | Fatigue | |
| 113226658 | 11322665 | Heart rate increased | |
| 113226658 | 11322665 | Hypersensitivity | |
| 113226658 | 11322665 | Hyposmia | |
| 113226658 | 11322665 | Infection | |
| 113226658 | 11322665 | Influenza | |
| 113226658 | 11322665 | Injection site erythema | |
| 113226658 | 11322665 | Injection site oedema | |
| 113226658 | 11322665 | Injection site pain | |
| 113226658 | 11322665 | Injection site pruritus | |
| 113226658 | 11322665 | Joint dislocation | |
| 113226658 | 11322665 | Myalgia | |
| 113226658 | 11322665 | Nasal discharge discolouration | |
| 113226658 | 11322665 | Pruritus | |
| 113226658 | 11322665 | Pyrexia | |
| 113226658 | 11322665 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 113226658 | 11322665 | 1 | 20130319 | 0 | ||
| 113226658 | 11322665 | 2 | 20130614 | 0 | ||
| 113226658 | 11322665 | 3 | 20140108 | 0 | ||
| 113226658 | 11322665 | 4 | 20140417 | 0 | ||
| 113226658 | 11322665 | 5 | 20140514 | 0 | ||
| 113226658 | 11322665 | 6 | 20150102 | 0 | ||
| 113226658 | 11322665 | 7 | 20150119 | 0 | ||
| 113226658 | 11322665 | 8 | 20150914 | 0 | ||
| 113226658 | 11322665 | 9 | 20160404 | 0 |